Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease

Related Experiment Video

Updated: Oct 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

C H Hennekens1

  • 1Mount Sinai Medical Center-Miami Heart Institute and Department of Medicine, Epidemiology, and Public Health, University of Miami School of Medicine, Miami Beach, Florida 33140, USA. PROFCHHMD@prodigy.net

Clinical Cardiology
|July 11, 2001
PubMed

Insights

Managing global cardiovascular disease (CVD) risk, particularly elevated lipid levels, is crucial. Statins effectively reduce CVD events, yet many at-risk patients remain undertreated or not at treatment goals.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) poses a significant health burden.
  • Management of individual risk factors is important, but global risk assessment is optimal.
  • Elevated lipid levels are a major contributor to overall CVD risk.

Purpose of the Study:

  • To emphasize the importance of managing global CVD risk.
  • To highlight the role of lipid reduction in mitigating CVD.
  • To discuss the benefits and current underutilization of statins.

Main Methods:

  • Review of clinical guidelines and evidence regarding CVD risk management.
  • Focus on the role of lipid-lowering therapies, specifically statins.
  • Analysis of patient treatment status relative to established goals.

Main Results:

  • Elevated lipid values significantly contribute to global CVD risk.
  • Statins (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors) demonstrate clear clinical benefits in reducing myocardial infarction, stroke, and mortality.
  • A significant gap exists between the known benefits of statins and their actual use, with many at-risk patients undertreated or not achieving lipid goals.

Conclusions:

  • Comprehensive management of global CVD risk is essential for effective patient care.
  • Lipid reduction, particularly through statin therapy, is a cornerstone of CVD prevention.
  • Addressing the undertreatment and suboptimal goal attainment of statin therapy is critical to improve patient outcomes and reduce the incidence of cardiovascular events.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...